Lara Dani

514 total citations
20 papers, 355 citations indexed

About

Lara Dani is a scholar working on Epidemiology, Rheumatology and Dermatology. According to data from OpenAlex, Lara Dani has authored 20 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Rheumatology and 4 papers in Dermatology. Recurrent topics in Lara Dani's work include Inflammatory Myopathies and Dermatomyositis (11 papers), Eosinophilic Disorders and Syndromes (5 papers) and Cancer Diagnosis and Treatment (3 papers). Lara Dani is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (11 papers), Eosinophilic Disorders and Syndromes (5 papers) and Cancer Diagnosis and Treatment (3 papers). Lara Dani collaborates with scholars based in Sweden, Spain and Italy. Lara Dani's co-authors include Ingrid E. Lundberg, Maryam Dastmalchi, Antonella Notarnicola, Marie Holmqvist, Jayesh M. Pandya, Snjólaug Arnardottir, Andreas E. R. Fasth, Vivianne Malmström, Mei Zong and Eva Lindroos and has published in prestigious journals such as Annals of the Rheumatic Diseases, Human Reproduction and Lara D. Veeken.

In The Last Decade

Lara Dani

19 papers receiving 340 citations

Peers

Lara Dani
Salim Dönmez Türkiye
Lara Dani
Citations per year, relative to Lara Dani Lara Dani (= 1×) peers Salim Dönmez

Countries citing papers authored by Lara Dani

Since Specialization
Citations

This map shows the geographic impact of Lara Dani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Dani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Dani more than expected).

Fields of papers citing papers by Lara Dani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Dani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Dani. The network helps show where Lara Dani may publish in the future.

Co-authorship network of co-authors of Lara Dani

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Dani. A scholar is included among the top collaborators of Lara Dani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Dani. Lara Dani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogdanović, Darko, Kamran Mahmutyazıcıoğlu, Sam Ghazi, et al.. (2023). Autoimmune Pancreatitis Type 1 with Biliary, Nasal, Testicular, and Pulmonary Involvement: A Case Report and a Systematic Review. Journal of Clinical Medicine. 12(19). 6340–6340. 2 indexed citations
2.
Svensson, Åke, Angeles S. Galindo‐Feria, Antonella Notarnicola, et al.. (2023). POS1222 PROGRESSIVE PULMONARY FIBROSIS IN ANTI-SYNTHETASE SYNDROME: A SINGLE CENTER COHORT. Annals of the Rheumatic Diseases. 82. 946–946.
3.
Horuluoglu, Begum, Angeles S. Galindo‐Feria, Antonella Notarnicola, et al.. (2023). Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies. EMBO Molecular Medicine. 15(10). e17240–e17240. 15 indexed citations
4.
Cordel, N., F. Jouen, Janine A. Lamb, et al.. (2022). Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study. Lara D. Veeken. 62(4). 1711–1715. 5 indexed citations
5.
Galindo‐Feria, Angeles S., Lara Dani, Tsuneyo Mimori, et al.. (2022). ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Lara D. Veeken. 61(12). 4991–4996. 6 indexed citations
6.
Panić, Nikola, Lara Dani, Wiktor Rutkowski, et al.. (2021). Efficacy and safety of rituximab in autoimmune pancreatitis type 1: our experiences and systematic review of the literature. Scandinavian Journal of Gastroenterology. 56(11). 1355–1362. 9 indexed citations
7.
Dani, Lara, et al.. (2020). Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002–2016. Seminars in Arthritis and Rheumatism. 51(1). 331–337. 21 indexed citations
8.
Dani, Lara, Marie Holmqvist, María Ángeles Martínez, et al.. (2020). Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study.. PubMed. 38(1). 67–73. 18 indexed citations
9.
Parodis, Ioannis, et al.. (2019). G-CSF-induced aortitis: Two cases and review of the literature. Autoimmunity Reviews. 18(6). 615–620. 40 indexed citations
10.
Barsotti, Simone, Maryam Dastmalchi, Antonella Notarnicola, et al.. (2019). Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort. Seminars in Arthritis and Rheumatism. 50(3). 492–497. 27 indexed citations
11.
Alexanderson, Helene, Malin Regardt, Li Alemo Munters, et al.. (2018). Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study. The Journal of Rheumatology. 45(4). 538–546. 22 indexed citations
12.
Cupisti, Adamasco, F. Ciardella, E. Morelli, et al.. (2015). The Effect of Fenquizone on the Urinary Inhibitors of Calcium Oxalate Urolithiasis. Contributions to nephrology. 58. 184–186. 1 indexed citations
13.
Dani, Lara, et al.. (2013). SAT0187 Antibodies Against TIF1GAMMA in Cancer Associated Myositis Precede Cancer Symptoms and Persist After Cancer Removal. Annals of the Rheumatic Diseases. 72. A644–A644. 1 indexed citations
14.
Lundberg, Ingrid E., Lara Dani, Maryam Dastmalchi, et al.. (2013). P.14.5 Antibodies against TIF1-gamma in cancer associated myositis may precede cancer symptoms and persist after cancer removal. Neuromuscular Disorders. 23(9-10). 814–814. 1 indexed citations
15.
Pandya, Jayesh M., Andreas E. R. Fasth, Mei Zong, et al.. (2010). Expanded T cell receptor Vβ–restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis & Rheumatism. 62(11). 3457–3466. 59 indexed citations
16.
Cozzi, Franco, et al.. (2007). Mud-bath treatment in spondylitis associated with inflammatory bowel disease – a pilot randomised clinical trial. Joint Bone Spine. 74(5). 436–439. 31 indexed citations
17.
Antinori, S., et al.. (2003). Obstetric and prenatal outcome in menopausal women: a 12-year clinical study. Reproductive BioMedicine Online. 6(2). 257–261. 36 indexed citations
18.
Antinori, S., et al.. (1999). O-221. Laser-assisted hatching at the extremes of the IVF spectrum: first cycle and after 6 cycles; a randomized prospective trial. Human Reproduction. 14(Suppl_3). 122–123. 4 indexed citations
19.
Giovannetti, S., Giovanni Barsotti, Adamasco Cupisti, et al.. (1995). Oral Activated Charcoal in Patients with Uremic Pruritus. ˜The œNephron journals/Nephron journals. 70(2). 193–196. 34 indexed citations
20.
Giovannetti, S., Adamasco Cupisti, E. Morelli, et al.. (1994). Dipsogenic Factors Operating in Chronic Uremics on Maintenance Hemodialysis. ˜The œNephron journals/Nephron journals. 66(4). 413–420. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026